Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: Outcomes in a concurrent series of patients using modern criteria for remission

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3190-3198

  Starke, Robert M ^a   Raper, Daniel M S ^a   Payne, Spencer C ^a   Vance, Mary L ^a   Oldfield, Edward H ^a   Jane Jr , John A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CONSENSUS; CONTROLLED STUDY; ENDOSCOPIC SURGERY; ENDOSCOPIC TRANSSPHENOIDAL SURGERY; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; INTERMETHOD COMPARISON; KNOSP SCORE; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MICROSURGICAL TRANSSPHENOIDAL SURGERY; ORAL GLUCOSE TOLERANCE TEST; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RETROSPECTIVE STUDY; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; SINUSITIS; SMELLING DISORDER; SURGICAL TECHNIQUE; TASTE DISORDER; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; YOUDEN INDEX;

ACROMEGALY; ADENOMA; ADOLESCENT; ADULT; AGED; ENDOSCOPY; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMAN GROWTH HORMONE; HUMANS; MALE; MICROSURGERY; MIDDLE AGED; RETROSPECTIVE STUDIES; SPHENOID BONE; TREATMENT OUTCOME;

EID: 84881482571     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1036     Document Type: Article

References (47)

1. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008;93:61-67.
2. Fahlbusch R, Honegger J, Buchfelder M. Surgical management of acromegaly. Endocrinol Metab Clin NorthAm. 1992;21:669-692.
3. Fahlbusch R, Honegger J, Buchfelder M. Evidence supporting surgery as treatment of choice for acromegaly. J Endocrinol 1997; 155(suppl 1):S53-S55.
4. Laws ER. Surgery for acromegaly: evolution of the techniques and outcomes. Rev Endocr Metab Disord. 2008;9:67-70.
5. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus. 2010;29:E5.
6. Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg. 2002;97:293-298.
7. Gondim JA, Schops M, de Almeida JP, et al. Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary. 2010;13:68-77.
8. Hofstetter CP, Mannaa RH, Mubita L, et al. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus. 2010;29:E6.
9. Tabaee A, Anand VK, Barron Y, et al. Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg. 2009;111:545-554.
10. Yano S, Kawano T, Kudo M, et al. Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo). 2009;49:1-7.
11. Cappabianca P, Cavallo LM, Colao A, et al. Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg. 2002;45:193-200.
12. Dehdashti AR, Ganna A, Karabatsou K, Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery. 2008;62:1006-1015; discussion 1015-1017.
13. Frank G, Pasquini E. Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas. Front Horm Res. 2006;34:64-82.
14. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus. 2010;29:E7.
15. Gondim JA, Ferraz T, Mota I, et al. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country. Surg Neurol. 2009;72:15-19; discussion 19.
16. Kabil MS, Eby JB, Shahinian HK. Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg. 2005;48:348-354.
17. Rudnik A, Zawadzki T, Wojtacha M, et al. Endoscopic transnasal transsphenoidal treatment of pathology of the sellar region. Minim Invasive Neurosurg. 2005;48:101-107.
18. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000; 85:526-529.
19. Giustina A, Chanson P, Bronstein MD, et al. Aconsensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95:3141-3148.
20. Jane JA Jr, Starke RM, Elzoghby MA, et al. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab. 2011;96:2732-2740.
21. Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993; 33:610-617; discussion 617-618.
22. Altman DG. Practical Statistics for Medical Research. Boca Raton, FL: Chapman, Hall/CRC; 1999.
23. Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK. Acromegaly surgery in Manchester revisited-the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Clin Endocrinol (Oxf). 2012;76:399-406.
24. Albarel F, Castinetti F, Morange I, et al. Outcome of multimodal therapy in operated acromegalic patients: a study in 115 patients. Clin Endocrinol (Oxf). 2013;78(2):263-270.
25. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure.' Eur J Endocrinol. 2005;152:379-387.
26. Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res 2000;53(suppl 3):71-75.
27. De P, Rees DA, Davies N, et al. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab. 2003;88:3567-3572.
28. Esposito V, Santoro A, Minniti G, et al. Transsphenoidal adenomectomy for GH-, PRL-and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Neurol Sci. 2004;25:251-256.
29. Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1, 000 operations. Neuroendocrinology. 2006;83:230-239.
30. Minniti G, Jaffrain-Rea ML, Esposito V, et al. Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients. Acta Neurochir (Wien). 2001;143:1205-1211.
31. Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, Christ ER. Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien). 2005;147:243-251; discussion 250-251.
32. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab. 2001;86:4072-4077.
33. Oldfield EH. Unresolved issues: radiosurgery versus radiation therapy; medical suppression of growth hormone production during radiosurgery; and endoscopic surgery versus microscopic surgery. Neurosurg Focus. 2010;29:E16 (editorial).
34. Beauregard C, Truong U, Hardy J, Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf). 2003;58:86-91.
35. Zada G, Cavallo LM, Esposito F, et al. Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations. Neurosurg Focus. 2010; 29:E8.
36. Nishioka H, Haraoka J. Biochemical cure of acromegaly after transsphenoidal surgery despite residual tumor on magnetic resonance imaging: case report. Neurol Med Chir (Tokyo). 2008;48:311-313.
37. van Bunderen CC, van Varsseveld NC, Baayen JC, et al. Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging. Pituitary. 2013;16(2):158-167.
38. Marquez Y, Tuchman A, Zada G. Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications. Int J Endocrinol. 2012;2012:386401.
39. Shahlaie K, McLaughlin N, Kassam AB, Kelly DF. The role of outcomes data for assessing the expertise of a pituitary surgeon. Curr Opin Endocrinol Diabetes Obes. 2010;17:369-376.
40. Schofl C, Franz H, Grussendorf M, et al. Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol. 2012;168:39-47.
41. Kim MS, Jang HD, Kim OL. Surgical results ofgrowthhormone-secreting pituitary adenoma. J Korean Neurosurg Soc. 2009;45(5):271-274.
42. Shimon I, Cohen ZR, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 2001;48:1239-1243; discussion 1244-1235.
43. Wagenmakers MAEM, Netea-Maier RT, van Lindert EJ, Pieters GFFM, Grotenhuis AJA, Hermus ARMM. Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. Acta Neurochir. 2011;153:1391-1399.
44. Gondim JA, Almeida JP, de Albuquerque LAF, Games E, Schops M, Ferraz T. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: 408 results of 67 cases treated in a pituitary center. Neurosurg Focus. 2010;29:E7.
45. Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoplasmic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg. 2002;97:293-298.
46. Cappabianca P, Cavallo LM, Colao A, et al. Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg. 2002;45:193-200.
47. Kaltsas GA, Isidori AM, Florakis D, et al. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab. 2001;86:1645-1652.